Nicholas Investment Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-229,492
Closed -$13.7M 196
2022
Q2
$13.7M Buy
+229,492
New +$13.7M 1.29% 21
2016
Q2
Sell
-25,142
Closed -$1.59M 326
2016
Q1
$1.59M Sell
25,142
-4,017
-14% -$254K 0.12% 259
2015
Q4
$3.27M Buy
29,159
+5,677
+24% +$637K 0.23% 185
2015
Q3
$2.26M Buy
+23,482
New +$2.26M 0.16% 230